Table 3 Distribution of the examined cases in group II (cirrhotic patients with HCC) according to several factors (n = 30)
From: Serum level of hepcidin in cirrhotic patients as a marker for hepatocellular carcinoma
| Â | No. | % |
|---|---|---|
Tumor number | ||
 1 | 10 | 33.3 |
 2 | 6 | 20.0 |
 3 | 3 | 10.0 |
 > 3 | 11 | 36.7 |
Tumor size largest dimension (cm) | ||
 Min.–max. | 1.50–18.0 | |
 Mean ± SD. | 7.49 ± 5.08 | |
 Median (IQR) | 6.0 (3.0–12.0) | |
Portal vein thrombosis | 17 | 56.7 |
Infiltrate | 6 | 20.0 |
LNS metastases | 7 | 23.3 |
Distant metastases | 3 | 10.0 |
BCLC | ||
 A | 5 | 16.7 |
 B | 5 | 16.7 |
 C | 7 | 23.3 |
 D | 13 | 43.3 |